ReP USP - Resultado da busca

Filtros : "Annual Meeting Abstracts - ASH" Limpar

Filtros

USP affiliated authors
- clé, diego villa (1)
- faça, vitor marcel (1)
- machado neto, joão agostinho (1)
- martins, diego antonio pereira (1)
- ramos, flavia sacilotto donaires (1)

Trabalho de evento-resumo periodico
Clonal hematopoiesis in telomere biology disorders associates with the underlying germline defect and somatic mutations in POT1, PPM1D, and TERT promoter (2021)
Gutierrez-Rodrigues, Fernanda; Groarke, Emma M.; Clé, Diego Villa ; Patel, Bhavisha A.; Ramos, Flávia Sacilotto Donaires ; Spitofsky, Nina; Alemu, Lemlem; Santana, Bárbara Amélia Aparecida ; Kajigaya, Sachiko; Colla, Simona; Oliveira, Michel Michels de; Bonfim, Carmem M. S.; Calado, Rodrigo Tocantins ; Young, Neal S.
Source: Blood. Conference titles: Annual Meeting Abstracts - ASH. Unidade: FMRP
Subjects: HEMATOPOESE, TELÔMERO, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIERREZ-RODRIGUES, Fernanda et al. Clonal hematopoiesis in telomere biology disorders associates with the underlying germline defect and somatic mutations in POT1, PPM1D, and TERT promoter. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-151199. Acesso em: 24 jan. 2026. , 2021
APA
Gutierrez-Rodrigues, F., Groarke, E. M., Clé, D. V., Patel, B. A., Ramos, F. S. D., Spitofsky, N., et al. (2021). Clonal hematopoiesis in telomere biology disorders associates with the underlying germline defect and somatic mutations in POT1, PPM1D, and TERT promoter. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-151199
NLM
Gutierrez-Rodrigues F, Groarke EM, Clé DV, Patel BA, Ramos FSD, Spitofsky N, Alemu L, Santana BAA, Kajigaya S, Colla S, Oliveira MM de, Bonfim CMS, Calado RT, Young NS. Clonal hematopoiesis in telomere biology disorders associates with the underlying germline defect and somatic mutations in POT1, PPM1D, and TERT promoter [Internet]. Blood. 2021 ; 138 1111-1112.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1182/blood-2021-151199
Vancouver
Gutierrez-Rodrigues F, Groarke EM, Clé DV, Patel BA, Ramos FSD, Spitofsky N, Alemu L, Santana BAA, Kajigaya S, Colla S, Oliveira MM de, Bonfim CMS, Calado RT, Young NS. Clonal hematopoiesis in telomere biology disorders associates with the underlying germline defect and somatic mutations in POT1, PPM1D, and TERT promoter [Internet]. Blood. 2021 ; 138 1111-1112.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1182/blood-2021-151199
Trabalho de evento-resumo periodico
IGF1R-IRS1/2 pharmacological inhibitors act by distinct cellular and molecular mechanisms and reveals vulnerabilities for treatment of acute myeloid leukemia (2021)
Silva, Juan Luiz Coelho da ; Martins, Diego Antonio Pereira ; Silvestrini, Virginia Campos ; Machado Neto, João Agostinho ; Rego, Eduardo Magalhães ; Smolka, Marcus; Faça, Vitor Marcel ; Traina, Fabiola
Source: Blood. Conference titles: Annual Meeting Abstracts - ASH. Unidades: ICB, FM, FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, LINHAGEM CELULAR, INIBIDORES DE ENZIMAS, RECEPTORES DE INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Juan Luiz Coelho da et al. IGF1R-IRS1/2 pharmacological inhibitors act by distinct cellular and molecular mechanisms and reveals vulnerabilities for treatment of acute myeloid leukemia. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-153105. Acesso em: 24 jan. 2026. , 2021
APA
Silva, J. L. C. da, Martins, D. A. P., Silvestrini, V. C., Machado Neto, J. A., Rego, E. M., Smolka, M., et al. (2021). IGF1R-IRS1/2 pharmacological inhibitors act by distinct cellular and molecular mechanisms and reveals vulnerabilities for treatment of acute myeloid leukemia. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1182/blood-2021-153105
NLM
Silva JLC da, Martins DAP, Silvestrini VC, Machado Neto JA, Rego EM, Smolka M, Faça VM, Traina F. IGF1R-IRS1/2 pharmacological inhibitors act by distinct cellular and molecular mechanisms and reveals vulnerabilities for treatment of acute myeloid leukemia [Internet]. Blood. 2021 ; 138 1869.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1182/blood-2021-153105
Vancouver
Silva JLC da, Martins DAP, Silvestrini VC, Machado Neto JA, Rego EM, Smolka M, Faça VM, Traina F. IGF1R-IRS1/2 pharmacological inhibitors act by distinct cellular and molecular mechanisms and reveals vulnerabilities for treatment of acute myeloid leukemia [Internet]. Blood. 2021 ; 138 1869.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1182/blood-2021-153105

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2026